Show an ad over header. AMP

I am the FIRST

The importance of vaccine timing

More time between COVID vaccine doses may help build more durable immunity, experts say.

Why it matters: The three- or four-week interval between the first and second doses of the Pfizer and Moderna vaccines was relatively short — and may help explain why the U.S. is now preparing for third doses.

What they're saying: "When you make that decision to do a three- or four-week interval, it sacrifices length of protection and durability of protection," said Peter Hotez, dean of the National School of Tropical Medicine at Baylor College.

  • He said it was a smart decision to pursue that vaccine interval early on, "because so many Americans were losing their lives from COVID — 3,000 deaths per day — and we had to get people fully immunized."
  • But it also made boosters much more likely, he said.
  • Longer intervals between doses may allow the immune system time to mature, or allow antibodies to improve in quality while dwindling in number, John Moore, a professor of microbiology and immunology at Cornell, told MedPage Today.

Between the lines: On Thursday, a report from U.K. health officials offered similar observations.

  • COVID vaccines were more effective against symptomatic disease with at least six weeks between doses than with only three to four weeks between doses, the paper says.

What we're watching: Experts say the eight-month gap the U.S. is planning before third doses could offer a significant boost.

  • "That may be it for a while, we may not need annual boosters," Hotez told MedPage. "This could be the third and done."

Why the startup world needs to ditch "unicorns" for "dragons"

When Aileen Lee originally coined the term "unicorn" in late 2013, she was describing the 39 "U.S.-based software companies started since 2003 and valued at over $1 billion by public or private market investors."

Flashback: It got redefined in early 2015 by yours truly and Erin Griffith, in a cover story for Fortune, as any privately-held startup valued at $1 billion or more. At the time, we counted 80 of them.

Keep reading... Show less

Scoop: Facebook's new moves to lower News Feed's political volume

Facebook plans to announce that it will de-emphasize political posts and current events content in the News Feed based on negative user feedback, Axios has learned. It also plans to expand tests to limit the amount of political content that people see in their News Feeds to more countries outside of the U.S.

Why it matters: The changes could reduce traffic to some news publishers, particularly companies that post a lot of political content.

Keep reading... Show less

Scoop: Amazon quietly getting into live audio business

Amazon is investing heavily in a new live audio feature that's similar to other live audio offerings like Clubhouse, Twitter Spaces and Spotify's new live audio platform, sources tell Axios.

Why it matters: As with Amazon's efforts in podcasting and music subscriptions, the company sees live audio as a way to bolster the types of content it can offer through its voice assistant, Alexa, and its smart speaker products.

Keep reading... Show less

Hurricane Ida exposes America's precarious energy infrastructure

The powerful hurricane that plunged New Orleans into darkness for what could be weeks is the latest sign that U.S. power systems are not ready for a warmer, more volatile world.

The big picture: “Our current infrastructure is not adequate when it comes to these kinds of weather extremes,” Joshua Rhodes, a University of Texas energy expert, tells Axios.

Keep reading... Show less

"We must go further": 70% of adults in European Union are fully vaccinated

About 70% of adults in the European Union are fully vaccinated against COVID-19, Ursula von der Leyen, the president of the European Commission, said Tuesday.

Why it matters: The milestone makes the E.U. one of the world's leaders in inoculations, after an initially lagging vaccine campaign, the New York Times notes.

Keep reading... Show less

What Elizabeth Holmes jurors will be asked ahead of fraud trial

Jury selection begins today in USA v. Elizabeth Holmes, with the actual jury trial to get underway on Sept. 8.

Why it matters: Theranos was the biggest fraud in Silicon Valley history, putting both hundreds of millions of dollars and thousands of patients' health at risk.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories